Tissue plasminogen activator (tPA) for acute ischaemic stroke: why so much has been made of so little

• Sir Charles Gairdner Hospital, Hospital Avenue, Nedlands, WA 6009.

---

• 1. Hoffman J. Tissue plasminogen activator (tPA) for acute ischaemic stroke: why so much has been made of so little. Med J Aust 2003; 179: 333-334. <eMJA full text> <MJA full text>
• 2. Donnan G, David S, Levi C. Thrombolysis for acute ischaemic stroke: revisiting the evidence. Med J Aust 2003; 179: 386-389. <eMJA full text> <MJA full text>
• 3. David S, Parsons M, Butcher K, Szoeke C. Thrombolysis for acute ischaemic stroke: revisting the evidence. Med J Aust 2003; 179: 386-389. <eMJA full text> <MJA full text>
• 4. Ingall T, O’Fallon W, Louise T, et al. Initial findings of the rt-PA acute stroke treatment review panel. Cerebrovasc Dis 2003; 16 Suppl 4: S1-S125.
• 5. Tissue plasminogen activator for acute ischaemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333: 1581-1587.